Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin

Overview of attention for article published in PharmacoEconomics, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 1 X user
patent: 3 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Healtheconbot, 12 Apr 2018

#HealthEconJA Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin